Brief: Myriad Genetics Provides Update On Discussions With Unitedhealthcare Regarding Medical Policy For Pharmacogenetic Testing
10/12/2024 23:30
Dec 10 (Reuters) - Myriad Genetics Inc MYGN.O :
* MYRIAD GENETICS PROVIDES UPDATE ON DISCUSSIONS WITH
UNITEDHEALTHCARE REGARDING MEDICAL POLICY FOR PHARMACOGENETIC
TESTING
Source text: urn:newsml:reuters.com:*:nGNXkdXSl
Further company coverage: MYGN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Myriad Genetics
See all newsUS STOCKS ON THE MOVE-Hilton, MSCI, Tradeweb, Eli Lilly
US STOCKS ON THE MOVE-Hilton, MSCI, Tradeweb, Eli Lilly
Myriad jumps after agreeing to sell prenatal health testing business
Brief: Myriad Genetics To Sell Prenatal Health Testing Business To Labcorp
U.S. STOCKS ON THE MOVE- Medtronic, Comstock, Apple